Related Experiment Video
Updated: Oct 15, 2026

Detection of Abnormal Prion Protein by Immunohistochemistry
Published on: May 5, 2023
Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy
M Jeffrey1, G McGovern, C M Goodsir
1VLA Lasswade, Pentlands Science Park, Bush Loan, Penicuik, Midlothian, Scotland, UK.
Abstract:
Prion protein (PrP) from the brains of animals with transmissible spongiform encephalopathies is partially protease resistant (PrP(res)) compared with fully sensitive PrP (PrP(sen)) from uninfected brains. In most experimental models, PrP(res) is a reliable indicator of infectivity. Light microscopic studies have suggested that both PrP(sen) and disease-specific accumulations of PrP are associated with follicular dendritic cells (FDCs). Using immunogold electron microscopy, this study has demonstrated disease-specific accumulation of PrP in the spleens of C57 BL mice, 70 days after intracerebral infection with the ME7 strain of scrapie and at the terminal stage of disease at 170 days. At both stages, tingible body macrophages contained PrP within lysosomes and PrP was also detected at the plasmalemma of FDCs. In the light zone of follicles of terminally diseased mice, all FDC dendrites were arranged in the form of highly reactive or hyperplastic labyrinthine glomerular complexes, within which PrP was consistently seen between FDC processes in association with abundant electron dense material, interpreted as antigen-antibody complexes. Within some glomeruli, fibrillar forms of PrP consistent with amyloid were seen. At 70 days after challenge, large or hyperplastic labyrinthine complexes were rare and invariably labelled for PrP. However, sparse PrP labelling was also seen on simple FDC processes at this stage. The ubiquitous accumulation of extracellular PrP in complex glomerular dendrites of FDCs in spleens from terminally affected mice, contrasted with simple FDC profiles, sparse PrP and limited electron dense deposits in all but a few FDCs of 70-day post-infected mice. This suggests that FDCs continually release PrP from the cell surface, where it is associated with trapped antigen-antibody complexes and dendritic extension. It is likely that tingible body macrophages acquire PrP following phagocytosis of PrP within iccosomes or from the extracellular space around FDC dendrites. These studies would not support an intracellular phase of PrP accumulation in FDCs but show that PrP is produced in excess by scrapie-infected cells from where it is released into the extracellular space. We suggest that PrP(sen) is involved in dendritic extension or in the process of antibody-antigen trapping, perhaps as part of the binding mechanism for antigen-antibody complexes. Reproduced with the permission of Her Majesty's Stationery Office. Published by John Wiley & Sons, Ltd.
Insights
Prion protein (PrP) accumulates extracellularly in mouse spleens, particularly on follicular dendritic cells (FDCs) and within macrophages, indicating disease progression in scrapie. This extracellular accumulation suggests FDCs release PrP, which may be involved in antigen trapping.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Transmissible spongiform encephalopathies are characterized by abnormal prion protein (PrP) accumulation.
- Prion protein (PrP) exists in sensitive (PrP(sen)) and resistant (PrP(res)) forms; PrP(res) indicates infectivity.
- Follicular dendritic cells (FDCs) are implicated in the localization of both normal and disease-associated PrP.
Purpose of the Study:
- To investigate the ultrastructural localization of prion protein (PrP) in the spleens of mice infected with the ME7 scrapie strain.
- To determine the association of PrP with FDCs and other splenic cells at different stages of scrapie infection.
Main Methods:
- Immunogold electron microscopy was used to examine spleen tissues from infected C57 BL mice.
- Mice were analyzed at 70 days (early stage) and 170 days (terminal stage) post-infection with the ME7 scrapie strain.
Main Results:
- Disease-specific PrP accumulation was observed in the spleens at both early and terminal stages.
- PrP was detected within lysosomes of tingible body macrophages and on the plasmalemma of FDCs.
- In terminally diseased mice, PrP was consistently found extracellularly within complex FDC dendritic structures, often associated with electron-dense material (antigen-antibody complexes) and sometimes fibrillar forms resembling amyloid.
Conclusions:
- Follicular dendritic cells (FDCs) appear to continually release prion protein (PrP) from their surface, where it associates with trapped antigen-antibody complexes.
- Tingible body macrophages likely acquire PrP through phagocytosis of extracellular material or cellular debris.
- The findings support extracellular PrP accumulation in FDCs rather than an intracellular phase, suggesting PrP is released from infected cells and may play a role in antigen trapping or dendritic extension.

